Effects of human recombinant, plasma-derived and porcine von Willebrand factor in pigs with severe von Willebrand disease

Blood Coagulation and Fibrinolysis

Volumn 9, Issue 4, 1998, Pages 361-372

  Roussi, J ^a,b   Turecek, P L ^c   Andre P ^d   Bonneau, M ^e   Pignaud, G ^a   Bal Dit Sollier, C ^d   Schlokat, U ^c   Dorner, F ^c   Schwarz, H P ^c   Drouet, L ^a,d  

^a SAINT LOUIS HOSPITAL   (France)

^b RAYMOND POINCARÉ HOSPITAL   (France)

^c BAXTER HEALTHCARE CORPORATION   (United States)

^d HÔPITAL LARIBOISIÈRE   (France)

^e CEMAGREF   (France)

Author keywords

Animal models; Recombinant von Willebrand factor; Von Willebrand disease; Von Willebrand factor; Von Willebrand factor concentrates

Indexed keywords

VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ARTICLE; BLEEDING TIME; DISEASE SEVERITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SWINE; THROMBOCYTE ADHESION; VON WILLEBRAND DISEASE;

EID: 14444281424     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199806000-00009     Document Type: Article

References (42)

1. Bowie EJW, Fass DN, Owen CA. Hemostatic effect of transfused Willebrand factor in porcine von Willebrand's disease. Similarities to the human disease. Haemostasis 1980; 9: 352-365.
2. Brinkhous KM, Reddick RL, Read MS, Nichols TC, Bellinger DA, Griggs TR. von Willebrand factor and animal models: contributions to gene therapy, thrombotic thrombocytopenic purpura and coronary artery thombosis. Mayo Clin Proc 1991; 66: 733-742.
3. Badimon L, Badimon JJ, Chesebro JH, Fuster V. Von Willebrand factor and cardiovascular disease. Thromb Haemost 1993; 70: 111-118.
4. Bowie EJW, Owen CA, Zollman PE, Thompson JH Jr, Fass DN. Tests of hemostasis in swine: Normal values and values in pigs affected with von Willebrand's disease. Am J Vet Res 1973; 34: 1405-1407.
5. Roussi J, Samama CM, Vaiman M, Nichols T, Pignaud G, Bonneau M, et al. Von Willebrand factor function following successful SLA matched bone marrow transplantation between normal and von Willebrand pigs. Exp Hematol 1996; 24: 585-591.
6. Meyer D, Girma JP. von Willebrand factor: structure and function. Thromb Haemost 1993; 70: 99-104.
7. Bahnak BR, Lavergne JM, Ferreira V, Kerbiriou-Nabias D, Meyer D. Comparison of the primary structure of the functional domains of human and porcine von Willebrand factor that mediate platelet adhesion. Biochem Biopbys Res Commun 1992; 182: 561-568.
8. Lavergne JM, Piao YC, Ferreira V, Kerbiriou-Nabias D, Bahnak BR, Meyer D. Primary structure of the factor VIII binding domain of human, porcine, and rabbit von Willebrand factor. Biochem Biophys Res Commun 1993; 194: 1019-1024.
9. Sjöberg A, Seaman WT, Bellinger DA, Griggs TR, Nichols TC, Chowdhary BP. FISH mapping of the porcine vWF gene to chromosome 5q21 extends synteny homology with human Chromosome 12. Hereditas 1996; 124: 199-202.
10. Fischer BE, Schlokat U, Mitterer A, Reiter M, Mundt W, Turecek PL, et al. Structural analysis of recombinant von Willebrand factor produced in industrial scale fermentation of transformed CHO cells co-expressing recombinant furin. FEBS Lett 1995; 375: 259-262.
11. André P, Arbeille B, Drouet V, Hainaud P, Bal dit Sollier C, Caen JP, et al. Optimal antagonism of GPIIb/IIIa favors platelet adhesion by inhibiting thrombus growth: an ex-vivo capillary perfusion chamber study in the guinea pig. Arterioscler Thromb Vasc Biol 1996; 16: 56-63.
12. Schwarz HP, Turecek P, Pichler L, Mitterer A, Mundt W, Dorner F, et al. Recombinant von Willebrand factor. Thromb Haemost 1997; 78: 571-576.
13. Roussi J, André P, Samama CM, Pignaud G, Bonneau M, Lapone A, et al. Platelet functions and haemostasis parameters in pigs: absence of side effects of a procedure of general anaesthesia. Thromb Res 1996; 81: 297-305.
14. Ravanat C, Freund M, Dol F, Cadroy Y, Roussi J, Incardonat F, et al. Cross-reactivity of human molecular markers for detection of prethrombotic states in various animal species. Blood Coag Fibrinol 1995; 6: 446-455.
15. Evans RM, Austen DEG. Assay of ristocetin co-factor using fixed platelets and a platelet counting technique. Br J Haematol 1977; 37: 289-394.
16. Ruggeri ZM, Zimmerman TS. The complex multimeric composition of factor VIII/von Willebrand factor. Blood 1981; 57: 1140-1143.
17. Aihara M, Sawada Y, Ueno K, Morimoto S, Yoshida Y, de Serres M, et al. Visualization of von Willebrand factor multimers by immunoenzymatic stain using avidin-biotin peroxidase complex. Thromb Haemost 1986; 55: 263-267.
18. Brandt JT, Triplett DA, Musgravc K, Arkin C, Bovill EG, Lucas FV, et al. Factor VIII assays. Arch Pathol Lab Med 1988; 112: 7-12.
19. Austen DEG, Rhymes IL. A Laboratory Manual of Blood Coagulation. Oxford: Blackwell Scientific Publications; 1975. pp. 188-192.
20. Lang H, Oberreither M, Moritz B. A new chromogenic Factor VIII:C-Assay based on a system of human proteins [abstract]. Thromb Haemost 1991; 65: 943.
21. Mertz ET. The anomaly of a normal Duke's and a very prolonged saline bleeding time in swine suffering from an inherited bleeding disease. Am J Physiol 1942; 136: 360-362.
22. Lee ML, Popovsky MA, Kingdon HS. A two-phase linear regression model for biologic half-life data. J Lab Clin Med 1990; 115: 745-748.
23. Ruckebusch Y. Homéostasie circulatoire. In: Maloine SA (editor) Physiologie Pharmacologie Thérapeutique. Paris, 1981; 1: 91-118.
24. Wise RJ, Barr PJ, Wong PA, Kiefer MC, Brake AJ, Kaufman RJ. Expression of human proprotein processing enzyme: correct cleavage of the von Willebrand precursor at a paired aminoacid site. Proc Natl Acad Sci USA 1990; 87: 9378-9382.
25. Van de Ven WJ, Creemers JW, Rocbroek AJ. Furin: the prototype mammalian subtilisin-like preprotein-processing enzyme. Endoprotcolytic cleavage at paired basic residues of proproteins of the eukaryotic secretory pathway. Enzyme 1991; 45: 257-270.
26. Furlan M, Robles R, Affolter D, Meyer D, Baillod P. Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers. Proc Natl Acad Sci USA 1993; 90: 7503-7507.
27. Furlan M, Robles R, Lämmle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in-vivo proteolysis. Blood 1996; 87: 4223-4234.
28. Griggs TR, Webster WP, Cooper HA, Wagner RH, Brinkhous KM. Von Willebrand factor: gene dosage relationship and transfusion response in a bleeder swine - a new bioassay. Proc Natl Acad Sci USA 1974; 71: 2087-2090.
29. Brinkhous KM, Sandberg H, Garris JB, Mattsson C, Palm M, Griggs TR, et al. Purified human Factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs. Proc Natl Acad Sci USA 1985; 82: 8752-8756.
30. Turecek PL, Gritsch H, Pichler L, Auer W, Fischer B, Mitterer A, et al. In-vivo characterization of recombinant von Willebrand factor in dogs with von Willebrand disease. Blood 1997; 90: 3555-3567.
31. Weiss HJ, Sussman II, Hoyer LW. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on post-transfusion and dissociated factor VIII and in patients with von Willebrand's disease. J Clin Invest 1977; 60: 390-404.
32. Bjorkman S, Carlsson M, Berntorp E, Stenberg P. Pharmacokinetics of factor VIII in humans: obtaining clinically relevant data from comparative studies. Clin Pharmacokinet 1992; 22: 385-395.
33. Lollar P, Parker CG. Stoichiometry of the porcine factor VIII-von Willebrand factor association. J Biol Chem 1987; 262: 17572-17576.
34. Vlot AJ, Koppelman SJ, Meijers JCM, Damas C, Marijke van den Berg, Bouma BN, et al. Kinetics of Factor VIII-von Willebrand factor association. Blood 1996; 87: 1809-1816.
35. Morfini M, Mannucci PM, Tenconi PM, Longo G, Mazzucconi MG, Rodeghiero F, et al. Pharmacokinetics of monoclonal-purified and recombinant factor VIII in patients with severe von Willebrand disease. Thromb Haemost 1993; 70: 270-272.
36. Menache D, Aronson DL, Darr F, Montgomery RR, and the Cooperative Study Group. Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of FVIIIC synthesis. Br J Haematol 1996; 94: 740-745.
37. Healey JF, Lubin IM, Lollar P. The cDNA and derived amino acid sequence of porcine factor VIII. Blood 1996; 88: 4209-4214.
38. Webster WP, Mandel SR, Strike LE, Penick GD, Griggs TR, Brinkhous KM. Factor VIII synthesis: hepatic and renal allografts in swine with von Willebrand's disease. Am J Path 1976; 230: 1342-1348.
39. Roussi J, Samama CM, Vaiman M, Nichols T, Pignaud G, Bonneau M, et al. An experimental model for testing von Willebrand factor function: successfull SLA-matched bone marrow transplantation between normal and von Willebrand pigs. Exp Haematol 1996; 24: 585-591.
40. Nichols TC, Samama CM, Bellinger DA, Roussi J, Reddick RL, Bonneau M, et al. Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras. Proc Natl Acad Sci USA 1995; 92: 2455-2459.
41. Smiley RK, Tittley P, Rock G. Studies of the prolonged bleeding time in von Willebrand's disease. Thromb Res 1989; 53: 417-426.
42. Menache D, Aronson DL, New treatments of von Willebrand disease: plasma derived von Willebrand factor concentrates. Thromb Haemost 1997; 78: 566-570.